Pilot study for treating dry age-related macular degeneration (AMD) with high-dose omega-3 fatty acids

PharmaNutrition

Volumn 2, Issue 1, 2014, Pages 8-11

  Georgiou, Tassos ^a   Neokleous, Anastasia ^a   Nicolaou, Despina ^a   Sears, Barry ^b  

^a Ophthalmos Research and Educational Institute   (Cyprus)

^b The Inflammation Research Foundation   (United States)

Author keywords

Age related macular degeneration; Clinical treatment; Docosahexaenoic acid (DHA); Eicosapentaenoic acid; Eicosapentaenoic acid (EPA); Inflammation; Omega 3 fatty acids; Resolvins

Indexed keywords

EID: 84895907245     PISSN: 22134344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phanu.2013.10.001     Document Type: Article

References (30)

1. Friedman D.S., O'Colmain B.J., Muñoz B., Tomany S.C., McCarty C., de Jong P.T., et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004, 122:564-572.
2. Mitta V.P., Christen W.G., Glynn R.J., Semba R.D., Ridker P.M., Rimm E.B., et al. C-Reactive protein and the incidence of macular degeneration. JAMA Ophthalmol 2013, 131:507-513.
3. Francis P.J., Zhang H., Dewan A., Hoh J., Klein M.L. Joint effects of polymorphisms in the HTRA1, LOC387715/ARMS2 and CFH genes on AMD in a Caucasian population. Mol Vis 2008, 14:1395-1400.
4. Forrester J.V. Bowman lecture on the role of inflammation in degenerative disease of the eye. Eye 2013, 27:340-352.
5. Miller J. Age related macular degeneration revised-piecing the puzzle: The LXIX Edward Jackson memorial lecture. Am J Ophthalmol 2013, 155:1-35.
6. Barouch F.C., Miller J.W. The role of inflammation and infection in age related macular degeneration. Int Ophthalmol Clin 2007, 47:185-197.
7. Trowbridge H.O. Inflammation: A review of the process 1997, Quintessence Publishing, Hanover Park, IL.
8. Serhan C.N., Ward P.A., Gilroy D.W., Ayoub S.S. Fundamentals of inflammation 2010, Cambridge University Press, Cambridge, England.
9. Serhan C.N. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Ann Rev Immunol 2007, 25:101-137.
10. Serhan C.N., Chiang N. Resolution phase lipid mediators of inflammation: agonists of resolution. Curr Opin Pharmacol 2013, 13:632-640.
11. Serhan C.N., Chiang N., Van Dyke T.E. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008, 8:349-361.
12. Serhan C.N., Arita M., Hong S., Gotlinger K. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers. Lipids 2004, 39:1125-1132.
13. Connor K.M., San Giovanni J.P., Lofqvist C., Aderman C.M., Chen J., Higuchi A., et al. Increased dietary intake of omega-3 polyunsaturated acids reduces pathological retinal angiogenesis. Nat Med 2007, 13:868-873.
14. Gerstenblith A.T., Baskin D.E., Shah C.P., Wolfe J.D., Fineman M.S., Kaiser R.S., et al. Electroretinographic effects of omega 3 fatty acid supplementation on dry age related macular degeneration. JAMA Ophthalmol 2013, 131:365-369.
15. Age-Related Eye Diseases Study 2 Research Group The Lutein and zeaxanthin and omega 3 fatty acids for age-related macular degeneration. JAMA 2013, 309:2005-2015.
16. Age-Related Eye Disease Research Group The A randomized, placebo-controlled, clinical trial of high doses supplementation with vitamins C and E, beta carotene and zinc for age-related macular degeneration and vision loss. Arch Opthalmol 2001, 119:1439-1451.
17. Ouellet M., Emond V., Chen C.T., Julien C., Bourasset F., Oddo S., et al. Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study. Neurochem Int 2009, 55:476-482.
18. Chen C.T., Liu Z., Ouellet M., Calon F., Bazinet R.P. Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study. Prostaglandins Leukot Essent Fatty Acids 2009, 80:157-163.
19. Chen C.T., Liu Z., Bazinet R.P. Rapid de-esterification and loss of eicosapentaenoic acid from rat brain phospholipids: an intracerebroventricular study. J Neurochem 2011, 116:363-373.
20. Umhau J.C., Zhou W., Carson R.E., Rapoport S.I., Polozova A., Demar J., et al. Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J Lipid Res 2009, 50:1259-1268.
21. Sears B., Bailes J., Asselin B. Therapeutic uses of high-dose omega-3 fatty acids to treat comatose patients with severe brain injury. PharmaNutrition 2013, 1:86-89.
22. Sorgi P.J., Hallowell E.M., Hutchins H.L., Sears B. Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder. Nutr J 2007, 13:16.
23. Germano M., Meleleo D., Montorfano G., Adorni L., Negroni M., Berra B., et al. Plasma, red blood cell phospholipids and clinicalevaluation after chain omega-3 supplementation in children with attention deficit hyperactivity disorder (ADHD). Nutr Neurosci 2007, 10:1-9.
24. Stoll A.L., Severus W.E., Freeman M.P., Rueter S., Zboyan H.A., Diamond E., et al. Omega-3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999, 56:407-412.
25. Marangell L.B., Martinez J.M., Zboyan H.A., Kertz B., Kim H.F., Puryear L.J. A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry 2003, 160:996-998.
26. Martins J.G. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr 2009, 28:525-542.
27. Harris W.S. Expert opinion: omega-3 fatty acids and bleeding-cause for concern?. Am J Cardiol 2007, 99:44C-46C.
28. Salisbury A.C., Harris W.S., Amin A.P., Reid K.J., O'Keefe J.H., Spertus J.A. Relation between red blood cell omega-3 fatty acid index and bleeding during acute myocardial infarction. Am J Cardiol 2012, 109:13-18.
29. Yee L.D., Lester J.L., Cole R.M., Richardson J.R., Hsu J.C., Li Y., et al. Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition. Am J Clin Nutr 2010, 91:1185-1194.
30. Yokoyama M., Origasa H., Matsuzaki M., Matsuzawa Y., Saito Y., Ishikawa Y., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomized open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098.